tiprankstipranks
Trending News
More News >
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Hong Kong Market

Shanghai Junshi Biosciences Co., Ltd. Class H (1877) Financial Statements

Compare
4 Followers

Shanghai Junshi Biosciences Co., Ltd. Class H Financial Overview

Shanghai Junshi Biosciences Co., Ltd. Class H's market cap is currently HK$38.63B. The company's EPS TTM is HK$-0.25580136239999995; its P/E ratio is ―; Shanghai Junshi Biosciences Co., Ltd. Class H is scheduled to report earnings on April 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.95B¥ 1.50B¥ 1.45B¥ 4.02B¥ 1.59B
Gross Profit¥ 1.54B¥ 868.16M¥ 927.21M¥ 2.77B¥ 1.22B
Operating Income¥ -1.34B¥ -2.45B¥ -2.67B¥ -685.33M¥ -1.68B
EBITDA¥ -935.50M¥ -2.16B¥ -2.38B¥ -422.77M¥ -1.53B
Net Income¥ -1.28B¥ -2.28B¥ -2.58B¥ -728.18M¥ -1.67B
Balance Sheet
Cash & Short-Term Investments¥ 2.93B¥ 3.78B¥ 6.00B¥ 3.50B¥ 3.39B
Total Assets¥ 10.80B¥ 11.36B¥ 12.58B¥ 11.05B¥ 8.01B
Total Debt¥ 2.93B¥ 1.79B¥ 1.32B¥ 628.20M¥ 850.78M
Net Debt¥ 428.69M¥ -1.99B¥ -4.68B¥ -2.88B¥ -2.53B
Total Liabilities¥ 4.85B¥ 4.02B¥ 2.78B¥ 2.72B¥ 2.17B
Stockholders' Equity¥ 5.86B¥ 7.17B¥ 9.50B¥ 7.96B¥ 5.84B
Cash Flow
Free Cash Flow¥ -2.12B¥ -2.85B¥ -2.17B¥ -1.53B¥ -2.09B
Operating Cash Flow¥ -1.43B¥ -2.01B¥ -1.78B¥ -641.90M¥ -1.50B
Investing Cash Flow¥ -892.78M¥ -892.42M¥ -467.62M¥ -1.88B¥ -697.98M
Financing Cash Flow¥ 1.02B¥ 681.04M¥ 4.64B¥ 2.67B¥ 4.41B
Currency in CNY

Shanghai Junshi Biosciences Co., Ltd. Class H Earnings and Revenue History

Shanghai Junshi Biosciences Co., Ltd. Class H Debt to Assets

Shanghai Junshi Biosciences Co., Ltd. Class H Cash Flow

Shanghai Junshi Biosciences Co., Ltd. Class H Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis